Clinical Trial Update: Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating OP-3136 in advanced or metastatic solid tumors, including ER-positive/HER2-negative breast cancer, non-small cell lung cancer, and cast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• OP-3136

Snippet

Sponsor: Olema Pharmaceuticals, Inc. | Conditions: Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | Phase 1 | Status: RECRUITING